Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men

By Kirby R.S.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 182-186

Elsevier

Access to resources Recommend Favorite

Long-term treatment with doxazosin in men with benign prostatic hyperplasia: 10-year follow-up

By Dutkiewicz Sławomir  

International Urology and Nephrology, Vol. 36, Iss. 2, 2004-06 ,pp. : 169-173

Springer Publishing Company

Access to resources Recommend Favorite

Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia

By Baldwin K.C.   Ginsberg P.C.   Roehrborn C.G.   Harkaway R.C.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 203-208

Elsevier

Access to resources Recommend Favorite

Benign prostatic hyperplasia: a progressive disease of aging men

By Emberton M.   Andriole G.L.   de la Rosette J.   Djavan B.   Hoefner K.   Vela Navarrete R.   Nordling J.   Roehrborn C.   Schulman C.   Teillac P.   Tubaro A.   Nickel J.C.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 267-273

Elsevier

Access to resources Recommend Favorite

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial

By Kirby R.S.   Roehrborn C.   Boyle P.   Bartsch G.   Jardin A.   Cary M.M.   Sweeney M.   Grossman E.B.   Predict Study Investigators  

Urology, Vol. 61, Iss. 1, 2003-01 ,pp. : 119-126

Elsevier

Access to resources Recommend Favorite